CSI Market
Sign In | Register

Arena Pharmaceuticals Inc (ARNA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ARNA Annual Cash Flow →
A period-by-period view of cash flow from Arena Pharmaceuticals Inc to Dec 31 2020 helps clarify how Dec 31 2021's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Sep 30 2021) (Jun 30 2021) (Mar 31 2021) (Dec 31 2020)
Operating Activities
Income-616.43
Depreciation & amortization3.87
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
Research and Development in Process70.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation70.37
Gain (Loss) on Sale of Previously Unissued Stock by Subsidiary or Equity Investee, Nonoperating Income-13.87
Gains (Losses) on Extinguishment of Debt0.00
Investment Income Amortization Of Premium-
Investment Write Down-
Available For Sale Securities Gross Unrealized Gain Loss-
Conversion Of Stock Amount Converted-
Preferred Stock Dividends And Other Adjustments-
Non Cash Collaboration Consideration-
Non Cash Collaboration Revenue-
Non Cash Royalty Revenue-
Increase Decrease In Accrued Litigation Settlement-
Increase Decrease In Contract With Customer Liability-
Deconsolidation Gain Or Loss Amount-
Other Operating Activities Net-
Income taxes6.62
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable1.10
Increase (Decrease) in Accounts Payable and Accrued Liabilities5.62
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets16.46
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.25
Discontinued operations0.00
Net Cash flow from Operating Activities-452.02
Investing Activities
Capital Expenditures-0.99
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities1,004.61
Payments to Acquire Available-for-sale Securities, Debt-612.22
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development-70.00
Interest in Subsidiaries and Affiliates0.00
Cash Divested from Deconsolidation0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities321.40
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock139.81
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Repayments Of Sale Lease Back Financing Obligations-
Finance Lease Principal Payments-3.24
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities135.41
Effect of exchange rate on cash flow0.24
Discontinued operations0.00
Free Cash Flow-453.00
Total Cash Flow5.03
4 historic quarters locked

Sign in to unlock the full Arena Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Arena Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001080709-22-000008

Figures are derived from filed reports and may be restated. Historical data is subject to revision.